Formula Systems stock reaches all-time high at 151.78 USD

Published 03/11/2025, 22:02
Formula Systems stock reaches all-time high at 151.78 USD

Formula Systems 1985 Ltd ADR stock has achieved an all-time high, reaching 151.78 USD, surpassing its previous 52-week high of 151.31 USD. This milestone reflects a significant surge in investor interest and confidence in the company’s performance. Over the past year, the stock has delivered an impressive 67.9% total return, with a 59.3% gain year-to-date, underscoring its robust growth trajectory. According to InvestingPro analysis, the stock is currently trading slightly above its Fair Value. The company’s strategic initiatives and strong financial results have likely contributed to this positive momentum, attracting investors who are optimistic about its future prospects. With a market capitalization of $2.33 billion, Formula Systems has demonstrated solid revenue growth of 8.58% to $2.89 billion in the last twelve months. The company maintains a "GREAT" overall financial health score of 3.04 on InvestingPro. As Formula Systems continues to innovate and expand its market presence, its stock performance remains a focal point for market analysts and investors alike, with earnings results expected on November 20.

In other recent news, Sapiens International Corporation is reportedly involved in advanced discussions concerning a change in its ownership structure. Formula Systems, the parent company of Sapiens, is negotiating with U.S. investment funds to sell its controlling stake in the software firm. The discussions suggest a valuation of approximately $2 billion for Sapiens. This potential transaction marks a significant development for the company, although specific details about the potential buyers or the timeline for completing the transaction have not been disclosed. The news of these negotiations has drawn attention in the investment community, reflecting the strategic shifts within Formula Systems. Investors are closely watching these developments as they could impact Sapiens’ future operations and market presence. This information comes from a report by the Israeli news website Calcalist.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.